CA9 and cancer: HepG2 and Hep3B xenograft models showed varying expression levels of GLUT1 and Ki67 depending on heterogeneous CAIX expression, a hypoxia-inducible metal-enzyme that promotes cancer cell survival and invasion via HIF1α activation (Supplementary Fig. S3).